Article
Biliatresone: progress in biliary atresia study
27 Sept 2022
Abstract excerpt
BACKGROUND: Biliary atresia (BA) is one of the main causes of neonatal end-stage liver disease. Without timely diagnosis and treatment, most children with BA will develop irreversible liver fibrosis within the first two months. While current theorized causes of BA include viral infection, immune disorders, and genetic defects, the comprehensive etiology is still largely unknown. Recently, biliatresone attracted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
